(FY)Jun 30, 2024 | (FY)Jun 30, 2023 | |
---|---|---|
Operating cash flow (direct method) | ||
Cash income from operating activities | ||
Cash paid | 21.56%-313.54K | -399.72K |
Payments to suppliers for goods and services | 21.56%-313.54K | ---399.72K |
Direct interest received | 34.00%114.04K | --85.1K |
Operating cash flow | 36.59%-199.5K | ---314.62K |
Investing cash flow | ||
Cash flow from continuing investing activities | -39.60%-2M | -1.43M |
Capital expenditure reported | -43.89%-2.41M | ---1.67M |
Net PPE purchase and sale | 3,464.85%406.37K | ---12.08K |
Net business purchase and sale | ---- | --251.71K |
Cash from discontinued investing activities | ||
Investing cash flow | -39.60%-2M | ---1.43M |
Financing cash flow | ||
Cash flow from continuing financing activities | -100.68%-42.14K | 6.16M |
Net issuance payments of debt | ---- | ---10.44K |
Net common stock issuance | ---- | --6.17M |
Net other financing activities | ---42.14K | ---- |
Cash from discontinued financing activities | ||
Financing cash flow | -100.68%-42.14K | --6.16M |
Net cash flow | ||
Beginning cash position | --4.41M | ---- |
Current changes in cash | -150.80%-2.24M | --4.41M |
End cash Position | -50.80%2.17M | --4.41M |
Free cash from | -32.00%-2.64M | ---2M |
Accounting Standards | US-GAAP | US-GAAP |
No Data
No Data